Next Article in Journal
Qualitative Insights on Barriers to Receiving a Second Dose of Measles-Containing Vaccine (MCV2), Oromia Region of Ethiopia
Next Article in Special Issue
Clinical and Diagnostic Features of Post-Acute COVID-19 Vaccination Syndrome (PACVS)
Previous Article in Journal
Correlates of Zero-Dose Status among Children Aged 12–23 Months in the Luambo Health District, Democratic Republic of Congo: A Matched Case–Control Study
Previous Article in Special Issue
Vaccines for the Elderly and Vaccination Programs in Europe and the United States
 
 
Article

Article Versions Notes

Vaccines 2024, 12(7), 701; https://doi.org/10.3390/vaccines12070701
Action Date Notes Link
article pdf uploaded. 21 June 2024 14:26 CEST Version of Record https://www.mdpi.com/2076-393X/12/7/701/pdf-vor
article supplementary file uploaded. 21 June 2024 14:26 CEST - https://www.mdpi.com/2076-393X/12/7/701#supplementary
article xml file uploaded 4 July 2024 12:01 CEST Original file -
article xml uploaded. 4 July 2024 12:01 CEST Update https://www.mdpi.com/2076-393X/12/7/701/xml
article pdf uploaded. 4 July 2024 12:01 CEST Updated version of record https://www.mdpi.com/2076-393X/12/7/701/pdf
article html file updated 4 July 2024 12:04 CEST Original file https://www.mdpi.com/2076-393X/12/7/701/html
Back to TopTop